Figures & data
Figure 1. Effects of quercetin and acrylamide treatment on serotonin levels in the cerebral cortex of Wistar rats. Enzyme activity is expressed as ng/100 mg (n = 6). *p < 0.001 when compared with the control group (independent samples t-test between the control and the treated groups in brain). NSNon-significant as compared with the quercetin alone or quercetin and acrylamide (independent samples t-test between the control and the treated groups in brain).
Figure 2. Effects of quercetin and acrylamide treatment on interferon-γ levels in the cerebral cortex of Wistar rats. Enzyme activity is expressed as pg/100 mg (n = 6). ***p < 0.0001 when compared with the control group (independent samples t-test between the control and the treated groups in brain). NSNon-significant as compared with quercetin alone or quercetin and acrylamide (independent samples t-test between the control and the treated groups in brain).
Figure 3. Effects of quercetin and acrylamide treatment on dopamine levels in the cerebral cortex of Wistar rats. Enzyme activity is expressed as ng/100 mg (n = 6). *p < 0.001 when compared to control group, ***p < 0.0001 when compared to control group (independent samples t-test between the control and the treated groups in brain).
Figure 4. Effects of quercetin and acrylamide treatment on 8-hydroxyguanine levels in the cerebral cortex of Wistar rats. Enzyme activity is expressed as ng/100 mg (n = 6). *p < 0.001 when compared to control group, ***p < 0.0001 when compared to control group (independent samples t-test between the control and the treated groups in brain). There was found significant difference between ACR alone and quercetin+ACR group showing the partial protection in quercetin+ACR group.
